| 产品名称 |
CAS号 |
分子式 |
含量 |
结构式 |
Benzoic acid, 4-(difluoromethoxy)-3-(1-methylethoxy)- |
159783-48-9 |
C11H12F2O4 |
98% |
暂无图片 |
Oxazole, 4-(bromomethyl)-2-[4-(difluoromethoxy)-3-(1-methylethoxy)phenyl]- |
1574285-38-3 |
C14H14BrF2NO3 |
98% |
暂无图片 |
Oxazole, 4-(chloromethyl)-2-[4-(difluoromethoxy)-3-(1-methylethoxy)phenyl]- |
2103191-10-0 |
C14H14ClF2NO3 |
98% |
暂无图片 |
4-Oxazolemethanol, 2-[4-(difluoromethoxy)-3-(1-methylethoxy)phenyl]- |
1574285-36-1 |
C14H15F2NO4 |
98% |
暂无图片 |
4-Oxazolemethanamine, 2-[4-(difluoromethoxy)-3-(1-methylethoxy)phenyl]- |
1574286-10-4 |
C14H16F2N2O3 |
98% |
暂无图片 |
937782-05-3
Difamilast 937782-05-3 |
937782-05-3 |
C23H24F2N2O5 |
98% |
暂无图片 |
3-AMINOPERYLENE |
35337-21-4 |
C20H13N |
98% |
暂无图片 |
3,5-二氯-6-乙基吡嗪甲酰胺
3,5-Dichloro-6-ethylpyrazinecarboxamide |
313340-08-8 |
C7H7Cl2N3O |
98% |
暂无图片 |
PYRROLO[1,2-F][1,2,4]TRIAZIN-4-AMINE
吡咯并[2,1-F][1,2,4]三嗪-4-胺 |
159326-68-8 |
C6H6N4 |
98% |
暂无图片 |
7-碘吡咯并[2,1-F][1,2,4]三嗪-4-胺
4-amino-7-iodopyrrolo[2,1-f][1,2,4]triazine |
1770840-43-1 |
C6H5IN4 |
98% |
暂无图片 |
1-((3-氟-4-(甲基氨基甲酰基)苯基)氨基)环丁烷羧酸甲酯
methyl 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino) cyclobutanecarboxylate |
2227589-23-1 |
C14H17FN2O3 |
98% |
暂无图片 |
Gilteritinib hemifumarate
Gilteritinib hemifumarate |
1254053-84-3 |
C62H92N16O10 |
98% |
暂无图片 |
3-bromo-6-ethyl-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carbonitrile |
2043019-98-1 |
C12H15BrN4O |
98% |
暂无图片 |
1-((3-氟-4-(甲基氨基甲酰基)苯基)氨基)环丁烷羧酸
1-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutane-1-carboxylic acid |
2227589-22-0 |
C13H15FN2O3 |
99% |
暂无图片 |
罗沙司他中间体
methyl2-(chloromethyl)-4-phenoxybenzoate |
1455091-04-9 |
C15H13ClO3 |
98% |
暂无图片 |
2-[(甲氧基羰基甲基)(甲苯-4-磺酰)氨基]甲基-4-苯氧基苯甲酸甲酯
2-{[(methoxycarbonylmethyl)(toluene-4-sulfonyl)amino]methyl}-4-phenoxybenzoic acid methyl ester |
1455091-06-1 |
C25H25NO7S |
98% |
暂无图片 |
罗沙司他N-1
methyl 2-(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxamido)acetate |
1421312-36-8 |
C20H20N2O4 |
98% |
暂无图片 |
NSC25824
NSC25824 |
5465-67-8 |
C11H15NO4S |
98% |
暂无图片 |
